CAPS Rating

CheapHessian (< 20)

Results 1 - 20 of 45 : 1 2 3 Next »
Top Pick Start Date Ticker CAPS Rating Call Time Frame Start Price Today (Change) Stock Gain Index Gain Score End Date Pitch
17/03/2014 FNV.US 3 out of 5 Outperform 5Y $52.43 $46.63 (-1.85%) -11.06% +1.21% -12.27
17/03/2014 TGD.US 2 out of 5 Outperform 5Y $1.70 $1.36 (-1.45%) -20.00% +1.21% -21.21
17/03/2014 LODE.US 1 out of 5 Outperform 5Y $1.94 $1.68 (-1.18%) -13.40% +1.21% -14.61
17/03/2014 GDXJ.US 3 out of 5 Outperform 5Y $44.33 $35.86 (-2.82%) -19.11% +1.21% -20.31
17/03/2014 AEM.US 3 out of 5 Outperform 5Y $34.37 $28.29 (-0.67%) -17.69% +1.21% -18.90
17/03/2014 ANV.US 2 out of 5 Outperform 5Y $6.37 $3.66 (-4.69%) -42.54% +1.21% -43.75
17/03/2014 GG.US 3 out of 5 Outperform 5Y $28.45 $24.55 (-0.65%) -13.71% +1.21% -14.91
29/02/2012 16/03/2014 AMZN.US 3 out of 5 Underperform 3Y $179.70 $337.15 (+3.87%) +87.62% +36.76% -50.86
26/02/2013 EXK.US 3 out of 5 Outperform 5Y $6.21 $4.42 (-1.56%) -28.82% +25.45% -54.28
11/02/2013 FSM.US 2 out of 5 Outperform 5Y $4.47 $3.90 (-1.52%) -12.75% +23.78% -36.54
11/02/2013 PAAS.US 3 out of 5 Outperform 5Y $16.77 $12.85 (-1.68%) -23.39% +23.78% -47.17
05/02/2013 RIC.US 3 out of 5 Outperform 5Y $3.20 $1.28 (+0.79%) -60.00% +24.93% -84.93
05/02/2013 AXU.US 2 out of 5 Outperform 5Y $4.58 $1.27 (-6.62%) -72.27% +24.93% -97.20
04/02/2013 SSRI.US 3 out of 5 Outperform 5Y $12.09 $9.61 (-3.12%) -20.51% +24.95% -45.47
04/02/2013 GORO.US 1 out of 5 Outperform 5Y $12.77 $4.76 (+0.21%) -62.72% +24.95% -87.67
24/01/2013 SGSVF.US 2 out of 5 Outperform 5Y $2.51 $0.67 (-4.89%) -73.49% +25.93% -99.42
23/01/2013 NRT.US 3 out of 5 Outperform 1Y $22.71 $24.39 (+0.83%) +7.41% +25.95% -18.54
23/01/2013 POT.US 4 out of 5 Outperform 5Y $39.68 $35.43 (+0.83%) -10.71% +25.95% -36.66
23/01/2013 CPE.US 2 out of 5 Outperform 5Y $5.22 $9.61 (+0.52%) +84.10% +25.95% +58.15
14/01/2013 IAG.US 3 out of 5 Outperform 5Y $10.58 $3.47 (-2.25%) -67.21% +27.87% -95.08
Results 1 - 20 of 45 : : 1 2 3 Next »

For details about CAPS-UK, and the conditions you agree to be bound by, please see our Terms and Conditions.